Please login to the form below

Not currently logged in
Email:
Password:

Rare Diseases and Orphan Drugs


Rare Diseases and Orphan Drugs

This category relates to the marketing of an orphan drug (for rare diseases or disorders), at any phase of the product life cycle. Entrants will need to demonstrate a thorough understanding of the specific environment and show appropriate marketing approach to drive the business forward.

Work conducted during the 18-month period between July 2010 and December 2011 will be eligible.


Judging criteria:

  • Recognition of the specific health environment
  • Evidence that the drug eas built upon customer insight
  • Explanation of positioning and evidence of effective brand building
  • Market access strategy & execution
  • Effective integration of tailored marketing tools and activities
  • Evidence of changed behaviours and enhanced health outcomes



Sponsors

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Syneos Health™

Syneos Health™ is the only fully integrated biopharmaceutical solutions organization. Our company, including a Contract Research Organization (CRO) and Contract...

Latest intelligence

No incentive for a cure
The paradox of ‘cost-effective but unaffordable’ life-saving medicines...
Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...

Infographics